当前位置: 首页 > 期刊 > 《青岛大学医学院学报》 > 20192
编号:13557099
2型糖尿病进程中小鼠下丘脑室旁核和视上核nesfatin`-1表达(6)
http://www.100md.com 2019年4月1日 《青岛大学学报(医学版)》 20192
     [29]MASUO K. Nesfatin`-1 could be a strong candidate obesity or diabetes medication, if blood pressure elevation can be controlled[J]. Hypertension Research:Official Journal of the Ja`-panese Society of Hypertension, 2014,37(2):98`-99.

    [30]ALGUL S, OZCELIK O. Evaluating the levels of nesfatin`-1 and ghrelin hormones in patients with moderate and severe major depressive disorders[J]. Psychiatry Investigation, 2018,15(2):214`-218.

    [31]GUO Y, LIAO Y, FANG G, et al. Increased nucleobindin`-2(NUCB2)transcriptional activity links the regulation of insulin sensitivity in type 2 diabetes mellitus[J]. Journal of Endocrinological Investigation, 2013,36(10):883`-888.

    [32]ALGUL S, OZKAN Y, OZCELIK O. Serum nesfatin`-1 levels in patients with different glucose tolerance levels[J]. Physiological Research, 2016,65(6):979`-985.

    [33]ZHAI Ting, LI Shizhen, FAN Xintong, et al. Circulating nesfatin`-1 levels and type 2 diabetes:a systematic review and Meta`-analysis[J]. 2017, 2017:7687098.

    [34]TANIDA M, GOTOH H, YAMAMOTO N, et al. Hypothalamic nesfatin`-1 stimulates sympathetic nerve activity via hypothalamic ERK signaling[J]. Diabetes, 2015,64(11):3725`-3736., http://www.100md.com(李晓玲 刘媛 宋莉敏 董静)
上一页1 2 3 4 5 6